APA (7th ed.) Citation

Layne, K. A., Wood, D. M., & Dargan, P. I. (2020). Gadolinium-based contrast agents – what is the evidence for 'gadolinium deposition disease' and the use of chelation therapy? Clinical Toxicology (15563650), 58(3), 151. https://doi.org/10.1080/15563650.2019.1681442

Chicago Style (17th ed.) Citation

Layne, Kerry A., David M. Wood, and Paul I. Dargan. "Gadolinium-based Contrast Agents – What Is the Evidence for 'Gadolinium Deposition Disease' and the Use of Chelation Therapy?" Clinical Toxicology (15563650) 58, no. 3 (2020): 151. https://doi.org/10.1080/15563650.2019.1681442.

MLA (9th ed.) Citation

Layne, Kerry A., et al. "Gadolinium-based Contrast Agents – What Is the Evidence for 'Gadolinium Deposition Disease' and the Use of Chelation Therapy?" Clinical Toxicology (15563650), vol. 58, no. 3, 2020, p. 151, https://doi.org/10.1080/15563650.2019.1681442.